跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cytochalasin B
首页
药物
Cytochalasin B
Experimental
Small Molecule
Cytochalasin B
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
29
H
37
NO
5
CAS 编号
14930-96-2
UNII ID
3CHI920QS7
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of inducing fenestrae
US 2007184549 A1
申请人: SHIMA DAVID T
优先权: 2005
US
Cell membrane microvesicles targeting inflammation region and application of cell membrane microvesicles
CN 113262212 A
申请人: UNIV PEKING SCHOOL STOMATOLOGY
优先权: 2021
CN
Nucleated mesenchymal stem cells as well as preparation method and application thereof
CN 117844746 A
申请人: UNIV KUNMING SCIENCE & TECHNOLOGY
优先权: 2024
CN
Preparation method, product and application of cell membrane self-assembled nano-vesicle carrier
CN 118086193 A
申请人: SCHOOL OF STOMATOLOGY KUNMING MEDICAL UNIV YUNNAN STOMATOLOGICAL HOSPITAL
优先权: 2024
CN
Cytorelaxin compound and application thereof based on activity of resisting methicillin-resistant staphylococcus aureus
CN 121698850 A
申请人: INST MICROBIOLOGY CAS
优先权: 2024
CN
CD19-targeted extracellular vesicle as well as preparation method and application thereof
CN 119592515 A
申请人: NANJING DRUM TOWER HOSPITAL
优先权: 2024
CN
Extracellular vesicle preparation rich in mitochondria as well as preparation method and application of extracellular vesicle preparation
CN 121759399 A
申请人: ZHEJIANG PROVINCIAL PEOPLES HOSPITAL
优先权: 2025
CN
Synthesis method of cytochalasin natural product curtachalasin B
CN 122010819 A
申请人: UNIV NANKAI
优先权: 2026
CN
Preparation method and application of enucleated mesenchymal stem cells capable of releasing apoptotic bodies in situ
CN 122081213 A
申请人: UNIV ZHENGZHOU
优先权: 2026
CN
药物
反馈